Cardiology electrodes, which are similar to small plastic patches, are positioned on the skin of the arms, chest, and legs. These electrodes are then connected to an electrocardiogram (ECG) machine with lead wires. The ECG machine analyzes the signals from the electrodes and generates an electrocardiogram, which displays the heart’s electrical activity. This diagnostic tool is utilized to detect cardiovascular events like heart attacks, heart failure, irregular heartbeats, endocarditis, and other conditions. Moreover, cardiology electrodes are crucial for verifying the correct placement of a pacemaker and evaluating the effectiveness of heart disease treatment medications. As an example, 3M, a conglomerate corporation based in the United States, provides prewired neonatal electrodes for ECG monitoring of newborn babies under the brand name 3M Red Dot, which are crafted from soft cloth material.
The projected worth of the global market for cardiology electrodes for 2022 is approximately US$127.93 mn, with an anticipated Compound Annual Growth Rate (CAGR) of 5.3% from 2023 to 2030.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4618
The global cardiology electrodes market is projected to experience growth in the coming years due to the efforts of market players who are focusing on the development of new cardiology electrodes. One such example is the use of Pulse Technologies Inc.’s proprietary Hierarchical Surface Restructuring (HSR) technology in Cardionomic’s Cardiac Pulmonary Nerve Stimulation (CPNS) System, which is designed to cure individuals having Acute Decompensated Heart Failure (ADHF). Cardionomic, Inc., a privately held company located in the United States that produces heart failure products, is responsible for the development and manufacturing of this system.
The need for healthcare products and services has significantly increased in the last ten years, especially in developed and high-growth economies, due to the rising aging population. The global market for cardiology electrodes has experienced growth, primarily driven by the increasing prevalence of cardiovascular diseases. As per the Centers for Disease Control and Prevention (CDC) report from July 2022, heart disorder is the primary reason of death in the United States, affecting males, females, and individuals of all ethnicities and races. In 2020, heart disease will have claimed the lives of above 697,000 persons in the United States, accounting for one in every 5 deaths. The primary reason of mortality from heart disorder was coronary heart disease (CAD), which caused 382,820 deaths. CAD affects 7.2% of the population aged 20 and above, which totals 20.1 million people.
Impact of the COVID-19 Pandemic:
The financial situation of businesses in all industries has been affected by the global COVID-19 pandemic and the resulting lockdowns in various countries. The healthcare industry’s entire supply chain has been impacted by the pandemic, primarily due to stringent lockdowns in certain countries. Nevertheless, the need for cardiology electrodes is predicted to rise during the COVID-19 pandemic because of the requirement for diagnostic equipment like ECG electrodes to diagnose and manage heart disorder in COVID-19 patients.
As an example, the NCBI (National Center for Biotechnology Information) published an article in March 2021 suggesting that COVID-19 can cause cardiac events like arrhythmias, myocarditis, and acute coronary syndrome. The virus responsible for COVID-19, SARS-CoV-2, is known to induce plaque rupture in blood vessels, leading to ischemia and acute coronary syndrome. The same study also indicates that pre-existing heart conditions can worsen due to COVID-19 infection. As a result, the use of cardiology electrodes as a critical diagnostic tool to monitor the heart health of COVID-19 positive patients is anticipated to increase, potentially contributing to the expansion of the global market for cardiology electrodes during the pandemic.
In January 2022, Koninklijke Philips N.V., a medical technology company, introduced the industry’s first complete at-home 12-lead electrocardiogram (ECG) solution designed for use in decentralized clinical trials. This innovative solution employs PCA 500 ECG patch data recording technology to enable participants to record data of comparable quality to site-based ECGs while at home. Moreover, it eliminates the need for onsite technicians, home nurses, or frequent site visits by guaranteeing highly secure data transmission.
Bittium, a provider of medical technology solutions, expanded its range of next-generation ECG electrodes in September 2021. These new Bittium OmegaSnap patch electrodes can facilitate ECG measurements with one, two, or three channels (1-CH, 2-CH, and 3-CH) when used with the Bittium Faros ECG device.
The market growth of cardiology electrodes is primarily limited by the need for biocompatibility. Since these electrodes come into direct contact with the body, it’s crucial to ensure that lead insulations and other materials used for marking and conducting the leads are biocompatible. Biocompatibility is especially important for skin-contacting materials like electrodes and electro-conductive gel, which must be suitable for their intended purpose.
The process of using cardiology electrodes involves measuring the internal ionic currents to detect and diagnose different cardiovascular disorders. This is achieved by establishing an electrical connection between the monitoring equipment and the patient through the use of the device. GE Healthcare, a medical technology company, emphasized in its report from February 2022 that correct placement of ECG leads is essential for the effective use of this diagnostic tool on both male and female patients. The inaccurate reading of waveforms due to misplacements can lead to the incorrect detection of ailments like myocardial infarction or arrhythmias, resulting in false-positive or false-negative results. Even though electrodes can’t be entirely non-polarizable or polarizable, Ag/AgCl contacts are an instance of a non-polarizable electrode that can’t be used for implantation because of biocompatibility problems. In addition, handcrafted electrodes have reproducibility concerns, further hampering the expansion of the cardiology electrode market during the projected timeframe.
- Promed Technology Co., Ltd.
- Leonhard Lang
- Conmed Corporation
- BPL Medical Technologies
- Koninklijke Philips N.V.
- Nissha Medical Technologies
- GE Healthcare (General Electric Company)
- FARUM sp. z o.o.
- Ambu A/S.
- Medtronic plc
- Cardinal Health
- Medico Electrodes International Ltd.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/4618
|The market size value in 2023|
Table of Contents with Major Points:
- Key Findings
- Definitions and Assumptions
- Definition of Cardiology Electrodes Market
- Market Dynamics
- Trends and Developments
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Cardiology Electrodes Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
- Data Sources
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4618
Explore More Related Insights:
- Gunshot Injuries Treatment Market
- Myelodysplastic Syndrome Treatment Market
- Age-related Macular Degeneration (AMD) Therapeutics Market
- Immunosuppressant Drugs Market
- Vertebral Compression Fracture Devices Market
- Batten Disease Treatment Market
- Anxiety Disorders and Depression Treatments Market
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027